Table 1 Clinical information of patients included in LC–MS/MS and PRM
From: Quantitative proteomics identified circulating biomarkers in lung adenocarcinoma diagnosis
Variable | LC–MS/MS | PRM | ||
|---|---|---|---|---|
LUAD (n = 10) | Control (n = 10) | LUAD (n = 10) | Control (n = 10) | |
Age (year) | 58.0 ± 12.3 | 44.4 ± 13.8 | 55.8 ± 8.5 | 44.5 ± 14.1 |
Gender; n (%) | ||||
 Male | 3 (30%) | 7 (70%) | 3 (30%) | 6 (60%) |
 Female | 7 (70%) | 3 (30%) | 7 (70%) | 4 (40%) |
Stage; n (%) | ||||
 I | 8 (80%) |  | 7 (70%) |  |
 II | 2 (20%) |  | 1 (10%) |  |
 III |  |  | 2 (20%) |  |
 IV |  |  |  |  |